Type Distribution of Human Papillomavirus in Adult African Women Diagnosed With Invasive Cervical Cancer

NCT01207999 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 591

Last updated 2012-11-22

No results posted yet for this study

Summary

The aim of the study is to assess the distribution of the most frequent types of human papillomavirus in African women diagnosed with invasive cervical cancer.

Conditions

Interventions

PROCEDURE

Collection of cervical cancer tissue samples

Cervical samples will be tested for histopathology diagnosis and human papillomavirus DNA testing.

OTHER

Data collection

Questionnaire completion

Sponsors & Collaborators

  • University of Cape Town

    collaborator OTHER
  • African Organization for Research and Training in Cancer (AORTIC)

    collaborator UNKNOWN
  • GlaxoSmithKline

    lead INDUSTRY

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Eligibility

Min Age
21 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-10-31
Primary Completion
2010-03-31
Completion
2010-03-31

Countries

  • Ghana
  • Nigeria
  • South Africa

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01207999 on ClinicalTrials.gov